Key takeaway
While locally acquired Crimean-Congo Hemorrhagic Fever and Rift Valley Fever are rare, and the risk of non-endemic viral hemorrhagic fevers is low, maintaining and enhancing surveillance and response mechanisms is crucial to ensure prompt detection and timely public health responses.
The National Institute for Communicable Diseases has released its Surveillance Report of viral haemorrhagic fevers, Rift Valley fever and yellow fever in humans for the period 2019 – 2023.
Detecting and responding to cases of viral hemorrhagic fever (VHF) is crucial for South Africa and is in accordance with International Health Regulations and the Global Health Security Agenda.
VHF, Rift Valley fever (RVF), and yellow fever (YF) pose risks to international travel and trade due to their potential to spread across borders. While South Africa has experienced few reports of Ebola virus disease (EVD), Marburg virus disease (MVD), Lassa fever (LF), and Lujo fever, recent outbreaks in neighbouring regions increase the risk of importation.
In addition, changing vector ecology due to climate change and land use impacts the epidemiology of these diseases. Currently, in South Africa, surveillance for VHF, RVF, and YF relies on passive methods, with clinical diagnoses confirmed by laboratory testing and reported through the National Notifiable Medical Conditions platform.
When taken in this context, and given that vaccines and treatments for most of these diseases are lacking, there is an urgent need to increase and improve surveillance methods and response capability to contain possible outbreaks.
Below is a summary of the findings in the report.
Over two-thirds of cases involved tick exposure, while others reported contact with animal tissues or blood or lived and worked in rural areas prone to tick exposure.
This report is a retrospective review of suspected or confirmed cases of VHF, RVF and YF occurring in South Africa, which were documented during the period 1 January 2019 to 31 December 2023.
The reviewed cases encompassed those submitted for investigation of viral hemorrhagic fevers, including EVD, MVD, LF, Lujo fever, VHF associated with New World arenavirus infections, CCHF or newly identified viruses causing haemorrhagic fever, Rift Valley fever (RVF), and yellow fever (YF).
The cases were documented by the Special Viral Pathogens Laboratory and the Arbovirus Reference Laboratory, situated within the Centre for Emerging Zoonotic and Parasitic Diseases at the National Institute of Communicable Diseases and National Health Laboratory Services.
Included in the review were case submission forms, case investigation forms, and unstructured case notes obtained from referring physicians, medical officers managing the NICD hotline, laboratory personnel involved in investigations, as well as district and provincial Department of Health investigation teams.
Laboratory-confirmed cases were categorized as those testing positive by reverse transcription polymerase chain reaction (RT-PCR), showing positivity for anti-virus immunoglobulin M (IgM), or demonstrating seroconversion through a four-fold increase in anti-virus immunoglobulin G (IgG) titer across serially collected blood samples.
A total of 232 cases were investigated during the reporting period. Of these, the endemic diseases of CCHF and RFV were the most frequent (77 and 90 cases, respectively).
Of the investigated cases, 11 cases were confirmed. These cases were as follows:
One case of Lassa Fever was confirmed, which proved fatal (2022).
Ten cases of CCHF were reported during the period, with one fatality noted.
No other cases of VHF, RVF, YF, or haemorrhagic fever associated with newly identified viruses occurred during the period under review.
Back to top
While the likelihood of non-endemic viral hemorrhagic fevers (VHF), Rift Valley fever (RVF), and yellow fever (YF) entering South Africa is minimal, and instances of locally acquired Crimean-Congo Hemorrhagic Fever (CCHF) and RVF are rare, enhanced and cohesive surveillance and response systems are vital. These measures are essential for promptly identifying imported cases and implementing effective public health interventions, particularly to mitigate potential outbreaks.
Summary Page: Surveillance of Viral Hemorrhagic Fevers in South Africa (2019-2023)- Summary Page
Report Download: Surveillance of viral haemorrhagic fevers, Rift Valley fever and yellow fever in humans, South Africa, 2019-2023 (PDF)
Back top
Disclaimer
This article is in no way presented as an original work. Every effort has been made to attribute quotes and content correctly. Where possible, all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here accurately reflects the original material. Should you find inaccuracies, out-of-date content or have any additional issues with our articles, please make use of the contact us form to notify us.